Risk Assessment of the Use of Autonomous Parvovirus-Based Vectors

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|3|6|567-582

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.3, Iss.6, 2003-12, pp. : 567-582

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

State-of-the-Art Lentiviral Vectors for Research Use: Risk Assessment and Biosafety Recommendations

By  

Current Gene Therapy, Vol. 9, Iss. 6, 2009-12 ,pp. : 459-474

Bentham Science Publishers

Access to resources Recommend Favorite

Environmental Risk Assessment of Clinical Trials Involving Modified Vaccinia Virus Ankara (MVA)-Based Vectors

By  

Current Gene Therapy, Vol. 13, Iss. 6, 2013-12 ,pp. : 413-420

Bentham Science Publishers

Access to resources Recommend Favorite

The use of in vitro metabolic parameters and physiologically based pharmacokinetic (PBPK) modeling to explore the risk assessment of trichloroethylene

By Hissink E.M.   Bogaards J.J.P.   Freidig A.P.   Commandeur J.N.M.   Vermeulen N.P.E.   van Bladeren P.J.  

Environmental Toxicology and Pharmacology, Vol. 11, Iss. 3, 2002-07 ,pp. : 259-271

Elsevier

Access to resources Recommend Favorite

Evaluation of Risks Related to the Use of Adeno-Associated Virus-Based Vectors

By  

Current Gene Therapy, Vol. 3, Iss. 6, 2003-12 ,pp. : 545-565

Bentham Science Publishers

Access to resources Recommend Favorite

Risk Assessment of Soybean-Based Phytoestrogens

By Kwack Seung Jun   Kim Kyu-Bong   Kim Hyung Sik   Yoon Kyung Sil   Lee Byung Mu  

Journal of Toxicology and Environmental Health, Vol. 72, Iss. 21-22, 2009-01 ,pp. : 1254-1261

Taylor & Francis Ltd

Access to resources Recommend Favorite